Drug Type Small molecule drug |
Synonyms Pidotimod (INN), Pidotimod Dispersible, NSC-759841 + [13] |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date China (01 Jan 2001), |
Regulation- |
Molecular FormulaC9H12N2O4S |
InChIKeyUUTKICFRNVKFRG-WDSKDSINSA-N |
CAS Registry121808-62-6 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Respiratory Tract Infections | China | 01 Jan 2001 | |
| Urinary Tract Infections | China | 01 Jan 2001 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Brain Infarction | Phase 3 | China | - | 25 Oct 2013 |
| Bacterial Infections | Phase 2 | China | 09 Nov 2014 | |
| Pulmonary Disease, Chronic Obstructive | Phase 2 | China | 09 Nov 2014 | |
| Gynecological infection | Phase 1 | China | 21 Nov 2013 | |
| Lower Respiratory Tract Infections | Phase 1 | China | 21 Nov 2013 | |
| Otitis Media | Phase 1 | China | 21 Nov 2013 | |
| Bronchitis | Phase 1 | China | 29 Oct 2013 | |
| Bronchitis | Phase 1 | China | - | 29 Oct 2013 |
| Bronchitis | Phase 1 | China | 29 Oct 2013 |





